Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop
For example, if you start a GLP-1 and notice you feel "raced" or "jittery," note down when this happens in relation to your thyroid medication
A separate 2024 study of 290 adults with obesity given oral semaglutide for three months found that free T3 decreased, free T4 rose slightly, and TSH fell during treatment
The Phase 3 trial study results were based on trial participants who took the highest dose of 36 milligrams for more than a year, or approximately 17 months
If insurance wont cover these, a compounded version of semaglutide may be offered
Just recently there was a, a big analysis, and I think that found that GLP-1 drugs were linked to a higher risk of skeletal disorders, so things like osteoporosis